JAK2 and acute lymphoblastic leukemia: This paradigm explaining the nuclear function of Pax5‐Jak2 may also be valid for all other 13 nuclear JAK2 fusion proteins identified in human B‐ALL, as they also retain the catalytic kinase domain (JH1) of JAK2 (Roberts et al, 2014; Akkari et al, 2020).